Mirtazapine
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 85650-52-8
Synonym(S): 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 MG | Y0000705-10-MG | In Stock | ₹ 16,516.80 |
Y0000705 - 10 MG
In Stock
Quantity
1
Base Price: ₹ 16,516.80
GST (18%): ₹ 2,973.024
Total Price: ₹ 19,489.824
grade
pharmaceutical primary standard
API family
mirtazapine
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
CN1CCN2C(C1)c3ccccc3Cc4cccnc24
InChI
1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3
InChI key
RONZAEMNMFQXRA-UHFFFAOYSA-N
Gene Information
human ... ADRA2A(150) , ADRA2B(151) , ADRA2C(152) , HTR2A(3356) , HTR2C(3358)
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences Mirtazapine United States Pharmacopeia (USP) Reference Standard | 85650-52-8 | MFCD00865427 | 350MG | -- | ₹ 2,37,438.65 | ||
Sigma Aldrich Fine Chemicals Biosciences Mirtazapine European Pharmacopoeia (EP) Reference Standard | 85650-52-8 | MFCD00865427 | | -- | ₹ 24,531.07 | ||
Mirtazapine solution | -- | ₹ 10,054.80 | ||
Mirtazapine | -- | ₹ 2,14,207.80 | ||
Mirtazapine | -- | ₹ 25,074.90 | ||
Mirtazapine | -- | ₹ 51,304.20 | ||
Mirtazapine for system suitability | -- | ₹ 16,516.80 | ||
2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine | -- | ₹ 890.00 - ₹ 1,45,604.00 | ||
85650-52-8 | 2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine | -- | ₹ 3,560.00 - ₹ 24,742.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Mirtazapine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA). Mirtazapine agonizes selective adrenergic and serotonergic receptors so that both NE release and 5-HT1A mediated serotonergic signaling are increased.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P261 - P264 - P270 - P271 - P301 + P312 - P304 + P340 + P312
Hazard Classifications
Acute Tox. 4 Oral - STOT SE 3
Target Organs
Central nervous system
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable